findmyKOL
Clinical trialNCT04036448CompletedObservational

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea

SponsorCelgeneEnrollment28Lymphoma, FollicularLymphoma, Mantle-CellMyelodysplastic Syndromes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Local Institution - S02

    Seoul, Seoul Teugbyeolsi, South Korea

  • Hallym University Medical Center

    Anyang, South Korea

  • Keimyung University Dongsan Hospital

    Daegu, South Korea

  • Kyungpook National University Hospital

    Daegu, South Korea

  • Local Institution - S03

    Daegu, South Korea

  • Local Institution - S07

    Daegu, South Korea

  • Local Institution - S11

    Goyang, South Korea

  • Chonnam National University Hwasun Hospital

    Hwasun, South Korea

  • Local Institution - S04

    Hwasun-gun, South Korea

  • Naitonal Health Insurance Service Ilsan Hospital

    Ilsan, South Korea

  • Gachon University Gil Mdical Center

    Incheon, South Korea

  • Local Institution - S09

    Incheon, South Korea

  • Jeonbuk National University Hospital

    Jeonju, South Korea

  • Local Institution - S10

    Jeonju, South Korea

  • Asan Medical Center

    Seoul, South Korea

  • Local Institution - S01

    Seoul, South Korea

  • Local Institution - S05

    Seoul, South Korea

  • Local Institution - S06

    Seoul, South Korea

  • Local Institution - S08

    Seoul, South Korea

  • Local Institution - S12

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • the Catholic University, St. Mary'S Hospital

    Seoul, South Korea

  • Yonsei University Severance Hospital

    Seoul, South Korea

  • Local Institution - S14

    Wŏnju, South Korea

  • Wonju Severance Christian Hospital

    Wŏnju, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Nov 2019
Primary completion
15 Aug 2023
Completion
15 Aug 2023
Last update posted
11 Mar 2025
Registered enrollment
28
Registry id
NCT04036448
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.